Relay Therapeutics (RLAY) Shares Issued (2019 - 2025)
Relay Therapeutics (RLAY) posted quarterly Shares Issued of $9.3 million for Q4 2025, up 499.47% year-over-year from $1.6 million in Q4 2024, and up 499.47% quarter-over-quarter from $1.6 million in Q4 2024.
Relay Therapeutics (RLAY) Shares Issued (2019 - 2025) Analysis & Trends
Relay Therapeutics (RLAY) has reported Shares Issued for 7 consecutive years, with $9.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Issued rose 499.47% year-over-year to $9.3 million; the TTM figure through Dec 2025 stood at $9.3 million (up 499.47% YoY), while the FY2025 annual figure was $9.3 million, up 499.47% from the prior year.
- Shares Issued climbed to $9.3 million in Q4 2025 per RLAY's latest filing, from $1.6 million in the prior quarter.
- Across five years, Shares Issued topped out at $12.4 million in Q4 2023 and bottomed at $1.6 million in Q4 2024.
- Historically, Shares Issued has averaged $5.4 million across 5 years, with a median of $1.8 million in 2021.
- Annual changes were most pronounced in 2023 — Shares Issued jumped 598.45% — and 2024, when it plunged 87.44%.
- Relay Therapeutics' Shares Issued stood at $1.8 million in 2021, then decreased by 2.16% to $1.8 million in 2022, then surged by 598.45% to $12.4 million in 2023, then slumped by 87.44% to $1.6 million in 2024, then soared by 499.47% to $9.3 million in 2025.
- Business Quant data shows RLAY's Shares Issued at $9.3 million in Q4 2025, $1.6 million in Q4 2024, and $12.4 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Relay Therapeutics | 4.34 Bn | 4.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.33 Mn |
| Dec 31, 2025 | 9.33 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Dec 31, 2023 | 12.39 Mn |
| Dec 31, 2023 | 12.39 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Dec 31, 2021 | 1.81 Mn |
| Dec 31, 2021 | 1.81 Mn |
| Dec 31, 2020 | 5.76 Mn |
| Dec 31, 2020 | 5.76 Mn |
| Dec 31, 2019 | 5.31 Mn |
| Dec 31, 2019 | 5.31 Mn |